A previous study demonstrated that RFC4 is overexpressed in CRC and is associated with tumor progression and poor survival results [57], which is consistent with the results found in this study that RFC4 was jointly up-regulated in the five datasets. This evidence concerns the gene RFC4 and neoplasm.